Mucosal Atomization Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Description
Mucosal Atomization Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
The global mucosal atomization devices market size reached US$ 723.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,074.2 Million by 2028, exhibiting a growth rate (CAGR) of 6.5% during 2023-2028.
Mucosal atomization devices refer to non-invasive intranasal medication delivery solutions that are used to administer atomized drugs in the nostril. The devices are commonly available in gas-propelled and electrical variants. They consist of a syringe and a small-sized atomizing tip at the end of a flexible applicator that is partially covered by foam to turn medication into a fine mist. Mucosal atomization devices are widely used for the treatment of chronic rhinosinusitis. They are safe to use, systematic, painless, flexible and offer needle-free drug delivery. They aid in delivering medication across mucosal membranes to the bloodstream without an intravenous line. As a result, these devices are widely used across hospitals, specialized clinics and ambulatory surgical centers.
Mucosal Atomization Devices Market Trends:
Significant growth in the healthcare industry across the globe is creating a positive outlook for the market. Mucosal atomization devices are widely used for the treatment of allergic rhinitis and sinus as they aid in rapid absorption of the medication and offer faster results. Additionally, the widespread adoption of gas-propelled mucosal atomization devices that contain highly pressurized nitrogen gas and offer convenient access to large mucosal surfaces is favoring the market growth. Moreover, various product innovations, such as the launch of auto-disposable variants that are safe and hygienic, are providing a thrust to the market growth. In line with this, the increasing preference for non-invasive medical devices that do not require needle punctures is positively impacting the market growth. Other factors, including the implementation of various government initiatives to promote public health, along with the increasing healthcare expenditures among the masses, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global mucosal atomization devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, technology and end user.
Breakup by Product Type:
Nasal Atomization Devices
Fiber-Optic Atomization Devices
Laryngo-Tracheal Atomization Devices
Bottle Atomizer Devices
Breakup by Technology:
Gas Propelled
Electrical
Breakup by End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Becton Dickinson and Company, DeVilbiss Healthcare LLC (Drive DeVilbiss Healthcare), Kurve Technology Inc., Life-Assist Inc., Medica Holdings LLC, MedTree (BTME Group Ltd.) and Teleflex Incorporated.
Key Questions Answered in This Report
1. What was the size of the global mucosal atomization devices market in 2022?
2. What is the expected growth rate of the global mucosal atomization devices market during 2023-2028?
3. What are the key factors driving the global mucosal atomization devices market?
4. What has been the impact of COVID-19 on the global mucosal atomization devices market?
5. What is the breakup of the global mucosal atomization devices market based on the product type?
6. What is the breakup of the global mucosal atomization devices market based on the technology?
7. What is the breakup of the global mucosal atomization devices market based on the end user?
8. What are the key regions in the global mucosal atomization devices market?
9. Who are the key players/companies in the global mucosal atomization devices market?
The global mucosal atomization devices market size reached US$ 723.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,074.2 Million by 2028, exhibiting a growth rate (CAGR) of 6.5% during 2023-2028.
Mucosal atomization devices refer to non-invasive intranasal medication delivery solutions that are used to administer atomized drugs in the nostril. The devices are commonly available in gas-propelled and electrical variants. They consist of a syringe and a small-sized atomizing tip at the end of a flexible applicator that is partially covered by foam to turn medication into a fine mist. Mucosal atomization devices are widely used for the treatment of chronic rhinosinusitis. They are safe to use, systematic, painless, flexible and offer needle-free drug delivery. They aid in delivering medication across mucosal membranes to the bloodstream without an intravenous line. As a result, these devices are widely used across hospitals, specialized clinics and ambulatory surgical centers.
Mucosal Atomization Devices Market Trends:
Significant growth in the healthcare industry across the globe is creating a positive outlook for the market. Mucosal atomization devices are widely used for the treatment of allergic rhinitis and sinus as they aid in rapid absorption of the medication and offer faster results. Additionally, the widespread adoption of gas-propelled mucosal atomization devices that contain highly pressurized nitrogen gas and offer convenient access to large mucosal surfaces is favoring the market growth. Moreover, various product innovations, such as the launch of auto-disposable variants that are safe and hygienic, are providing a thrust to the market growth. In line with this, the increasing preference for non-invasive medical devices that do not require needle punctures is positively impacting the market growth. Other factors, including the implementation of various government initiatives to promote public health, along with the increasing healthcare expenditures among the masses, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global mucosal atomization devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, technology and end user.
Breakup by Product Type:
Nasal Atomization Devices
Fiber-Optic Atomization Devices
Laryngo-Tracheal Atomization Devices
Bottle Atomizer Devices
Breakup by Technology:
Gas Propelled
Electrical
Breakup by End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Becton Dickinson and Company, DeVilbiss Healthcare LLC (Drive DeVilbiss Healthcare), Kurve Technology Inc., Life-Assist Inc., Medica Holdings LLC, MedTree (BTME Group Ltd.) and Teleflex Incorporated.
Key Questions Answered in This Report
1. What was the size of the global mucosal atomization devices market in 2022?
2. What is the expected growth rate of the global mucosal atomization devices market during 2023-2028?
3. What are the key factors driving the global mucosal atomization devices market?
4. What has been the impact of COVID-19 on the global mucosal atomization devices market?
5. What is the breakup of the global mucosal atomization devices market based on the product type?
6. What is the breakup of the global mucosal atomization devices market based on the technology?
7. What is the breakup of the global mucosal atomization devices market based on the end user?
8. What are the key regions in the global mucosal atomization devices market?
9. Who are the key players/companies in the global mucosal atomization devices market?
Table of Contents
143 Pages
- 1 Preface
- 2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
- 3 Executive Summary
- 4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
- 5 Global Mucosal Atomization Devices Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
- 6 Market Breakup by Product Type
- 6.1 Nasal Atomization Devices
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Fiber-Optic Atomization Devices
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Laryngo-Tracheal Atomization Devices
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Bottle Atomizer Devices
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 7 Market Breakup by Technology
- 7.1 Gas Propelled
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Electrical
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Clinics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Ambulatory Surgical Centers
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
- 10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
- 11 Value Chain Analysis
- 12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
- 13 Price Analysis
- 14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Becton Dickinson and Company
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 DeVilbiss Healthcare LLC (Drive DeVilbiss Healthcare)
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Kurve Technology Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 Life-Assist Inc.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 Medica Holdings LLC
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 MedTree (BTME Group Ltd.)
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 Teleflex Incorporated
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
